Benzoyl peroxide
Brand names: Acnecide, PanOxyl, Epiduo (with adapalene), Duac (with clindamycin)
Benzoyl peroxide is a topical keratolytic and antibacterial agent widely used for mild-to-moderate acne vulgaris.
Adult dose
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
Side effects
- Dry skin, erythema, skin exfoliation (peeling) and skin burning sensation — very common (≥1/10)
- Pruritus — common (≥1/100 to <1/10)
- Pain of skin (pain, stinging) — common
- Skin irritation (irritant contact dermatitis) — common
- Allergic contact dermatitis — uncommon (≥1/1,000 to <1/100)
- Swelling of the face and allergic reactions, including application site hypersensitivity and anaphylaxis — reported post-marketing, frequency not known
Interactions
- No interaction studies have been performed; however, drugs with desquamative, irritant and drying effects should not be used concurrently with benzoyl peroxide gel (SPC §4.5)
Clinical monograph
How it works
It releases reactive oxygen species that are bactericidal against Cutibacterium acnes, with additional keratolytic and comedolytic effects and no associated bacterial resistance.
Prescribing in practice
- It bleaches hair and dyed fabrics, so warn patients to avoid contact with clothing, towels, bedding and hair.
- Skin irritation, dryness and peeling are common, so start at a lower strength or reduced frequency if poorly tolerated.
- Avoid contact with the eyes, lips and mucous membranes.
Monitoring
No laboratory monitoring is required; assess skin tolerability and acne response clinically.
Counselling the patient
- It can bleach coloured clothing, towels, bedding and hair.
- Some dryness, redness and peeling is expected, especially when starting.
- Use sun protection, as skin may be more sensitive to sunlight.
Evidence & guidelines
NICE recommends benzoyl peroxide-containing regimens as first-line options for acne vulgaris.
Reference: SmPC Acnecide / Duac / Epiduo; NICE NG198 (Acne 2021); BAD Acne Guideline; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acne Severity Classification (IGA Scale) · Acne
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Rh(D) Immune Globulin Dosage for Maternal-Fetal Haemorrhage · Haematology in Pregnancy
- AREDS Classification of Age-related Macular Degeneration · Macular Degeneration
- Diabetic Macular Oedema (DMO) Classification · Diabetic Retinopathy
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD